A型肉毒素用于巨大切口疝修补的辅助治疗

doi:10.16139/j.1007-9610.2018.04.008

外科理论与实践 ›› 2018, Vol. 23 ›› Issue (04): 318-320.doi: 10.16139/j.1007-9610.2018.04.008

A型肉毒素用于巨大切口疝修补的辅助治疗

王平, 吴浩

浙江大学医学院附属杭州市第一人民医院疝和腹壁外科,浙江杭州 310006

收稿日期:2018-06-01 出版日期:2018-07-25 发布日期:2020-07-25
通讯作者: 吴浩,E-mail: 839817971@qq.com

Received:2018-06-01 Online:2018-07-25 Published:2020-07-25

摘要/Abstract

关键词: A型肉毒素, 切口疝, 弛缓性麻痹, 化学性组织结构分离

中图分类号:

R656.2

王平, 吴浩. A型肉毒素用于巨大切口疝修补的辅助治疗[J]. 外科理论与实践, 2018, 23(04): 318-320.

[1] Deerenberg EB, Timmermans L, Hogerzeil DP, et al.A systematic review of the surgical treatment of large incisional hernia[J]. Hernia,2015,19(1):89-101.
[2] Nguyen V, Shestak KC.Separation of anatomic components method of abdominal wall reconstruction-clinical outcome analysis and an update of surgical modifications using the technique[J]. Clin Plast Surg,2006,33(2):247-257.
[3] Ramirez OM, Ruas E, Dellon AL.“Components separation” method for closure of abdominal-wall defects: an anatomic and clinical study[J]. Plast Reconstr Surg,1990, 86(3):519-526.
[4] Novitsky YW, Elliott HL, Orenstein SB, et al.Transversus abdominis muscle release: a novel approach to posterior component separation during complex abdominal wall reconstruction[J]. Am J Surg,2012,204(5):709-716.
[5] Dressler D.Clinical applications of botulinum toxin[J]. Curr Opin Microbiol,2012,15(3):325-336.
[6] 朱力, 王恒樑, 黄留玉. 肉毒毒素研究进展[J]. 生物技术通讯,2005,16(2):186-190.
[7] Won CH, Lee HM, Lee WS, et al.Efficacy and safety of a novel botulinum toxin type a product for the treatment of moderate to severe glabellar lines: a randomized, double-blind, active-controlled multicenter study[J]. Dermatol Surg,2013,39(1 pt2):171-178.
[8] Smoot D, Zielinski M, Jenkins D, et al.Botox A injection for pain after laparoscopic ventral hernia: a case report[J]. Pain Med,2011,12(7):1121-1123.
[9] Ibarra-Hurtado TR, Nuño-Guzmán CM.Chemical components separation with botulinum toxin A: a novel technique to improve primary fascial closure rates of the open abdomen[J]. Hernia,2013,17(1):101-107.
[10] Ibarra-Hurtado TR, Nuño-Guzmán CM, Echeagaray-Herrera JE, et al.Use of botulinum toxin type a before abdominal wall hernia reconstruction[J]. World J Surg,2009,33(12):2553-2556.
[11] Cakmak M, Caglayan F, Somuncu S, et al.Effect of paralysis of the abdominal wall muscles by botulinum A toxin to intraabdominal pressure: an experimental study[J]. J Pediatr Surg,2006,41(4):821-825.
[12] Weissler JM, Lanni MA, Tecce MG, et al.Chemical component separation: a systematic review and meta-analysis of botulinum toxin for management of ventral hernia[J]. J Plast Surg Hand Surg,2017,51(5):366-374.
[13] Elstner KE, Jacombs AS, Read JW, et al.Laparoscopic repair of complex ventral hernia facilitated by pre-operative chemical component relaxation using Botulinum Toxin A[J]. Hernia,2016,20(2):209-219.
[14] Zendejas B, Khasawneh MA, Srvantstyan B, et al.Outcomes of chemical component paralysis using botulinum toxin for incisional hernia repairs[J]. World J Surg,2013, 37(12):2830-2837.
[15] Farooque F, Jacombs AS, Roussos E, et al.Preoperative abdominal muscle elongation with botulinum toxin A for complex incisional ventral hernia repair[J]. ANZ J Surg, 2016,86(1-2):79-83.
[16] Ibarra-Hurtado TR, Nuño-Guzmán CM, Miranda-Díaz AG, et al.Effect of botulinum toxin type A in lateral abdominal wall muscles thickness and length of patients with midline incisional hernia secondary to open abdomen management[J]. Hernia,2014,18(5):647-652.
[17] Zendejas B, Khasawneh MA, Srvantstyan B, et al.Outcomes of chemical component paralysis using botulinum toxin for incisional hernia repairs[J]. World J Surg,2013, 37(12):2830-2837.
[18] Bueno-Lledó J, Torregrosa A, Ballester N, et al.Preope-rative progressive pneumoperitoneum and botulinum toxin type A in patients with large incisional hernia[J]. Hernia,2017,21(2):233-243.
[19] Elstner KE, Read JW, Rodriguez-Acevedo O, et al.Preoperative progressive pneumoperitoneum complementing chemical component relaxation in complex ventral hernia repair[J]. Surg Endosc,2016,31(4):1-9.
[20] Smoot D, Zielinski M, Jenkins D, et al.Botox A injection for pain after laparoscopic ventral hernia: a case report[J]. Pain Medicine,2011,12(7):1121-1123.
[21] 王平, 吴浩, 黄永刚, 等. 化学性组织结构分离术治疗巨大切口疝一例[J]. 中华疝和腹壁外科杂志,2018,12(1):65-67.

A型肉毒素用于巨大切口疝修补的辅助治疗

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	李健文, 乐飞, 张云. 腹腔内和腹膜外微创技术治疗腹壁切口疝的思考[J]. 外科理论与实践, 2021, 26(5): 377-382.
[2]	乐飞, 李健文. 微创腹壁切口疝的术式进展、争议和展望[J]. 外科理论与实践, 2020, 25(03): 198-201.
[3]	李绍杰, 朱雷, 唐健雄. 切口疝修补术常见局部并发症的预防与处理[J]. 外科理论与实践, 2018, 23(04): 321-324.
[4]	王学虎, 赵渝. 腹腔镜腹壁切口疝修补术及并发症处理[J]. 外科理论与实践, 2018, 23(04): 302-305.
[5]	王明刚. 切口疝治疗的手术选择与核心策略[J]. 外科理论与实践, 2018, 23(04): 306-309.
[6]	孟云潇, 陈革, 李绍杰, 胡星辰, 黄磊, 蔡昭, 唐健雄. 开放式补片修补术治疗腹壁切口疝（附210例报告）[J]. 外科理论与实践, 2018, 23(04): 337-341.
[7]	何玉, 薛佩, 费健,. A型肉毒素对瘢痕防治的作用[J]. 外科理论与实践, 2017, 22(05): 450-454.
[8]	陈双, 宗振,. 术前渐进性人工气腹在治疗复杂腹壁缺损中的应用[J]. 外科理论与实践, 2016, 21(02): 108-110.
[9]	唐健雄, 郑民华, 田文, 陈双, 陈杰, 王明刚, 李健文,. 切口疝腹腔镜手术规范化操作专家共识[J]. 外科理论与实践, 2016, 21(02): 166-171.
[10]	邓磊, 林擎天, 金立, 侯宝生,. 腹壁切口疝的外科治疗[J]. 外科理论与实践, 2015, 20(01): 61-63.
[11]	唐健雄,. 进一步做好疝诊疗的规范化工作[J]. 外科理论与实践, 2013, 18(03): 193-197.
[12]	李基业,. 腹壁切口疝合成补片修补的感染原因及防治[J]. 外科理论与实践, 2013, 18(03): 202-206.
[13]	马颂章,. 当前腹壁切口疝治疗的几点建议[J]. 外科理论与实践, 2013, 18(03): 207-210.
[14]	邓先兆, 伍波, 樊友本, 刘溦薇, 康杰, 黄玉耀, 郑起,. 切口疝的“杂交”修复技术(附40例报告)[J]. 外科理论与实践, 2013, 18(03): 232-235.
[15]	李基业, 陈双, 唐健雄, 田文,. 腹壁切口疝诊疗指南(2012年版)[J]. 外科理论与实践, 2013, 18(03): 288-290.